News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Actinogen Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease
Experts
ScoPo’s Powerplays: Health stocks strap in for a ‘skittish’ ride
News
Top 10 at 10: The most gorgeous ASX stocks in early trade
Health & Biotech
ASX Health Stocks: ACCC gives the OK for API takeover by Wesfarmers
Health & Biotech
ASX Health Stocks: dorsaVi gets ISO certification; Actinogen to begin Phase 2 trial
News
Winners List: Here are the top 100 ASX small cap stocks for 2021
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
News
Closing Bell: ASX makes up lost ground, still finishes 0.54% down
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
News
10 at 10: These ASX stocks are the most imposing this morning
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
Health & Biotech
Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress
Health & Biotech
ASX Health Stocks: IDT shoots 20pc on COVID-19 deal with government, ImpediMed granted US FDA Breakthrough
Health & Biotech
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
Health & Biotech
